Skip to main content
. 2021 Feb 4;11:3015. doi: 10.1038/s41598-021-82566-w

Figure 2.

Figure 2

(a) Visual Analog Scale (VAS) scores significantly decreased 12 weeks after administration of nalfurafine when compared with baseline scores during daytime. The average VAS score improved from 50 to 25 mm (P < 0.001). (b) VAS scores significantly decreased 12 weeks after administration of nalfurafine when compared with baseline scores during nighttime. The average VAS score improved from 64 to 31 mm (P < 0.001). The error bars represent standard errors.